The board of directors of Avon Products Inc. (NYSE: AVP) have named Sherilyn McCoy as the company’s new CEO. McCoy has spent virtually her entire professional career with Johnson & Johnson (NYSE:…
RealtyTrac says foreclosure notices rose last month. (Reuters) The U.S. and UK discuss releasing strategic oil reserves to bring down fuel prices. (Reuters) Volcker says new inflation would be harmful to the…
US equities opened higher this morning following the report on a US non-farm payroll gain of 227,000 jobs (more coverage here). In Europe, the Greek debt swap deal went off smoothly, but…
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Arch Coal, Inc. (NYSE: ACI) Cut to Market Perform at BMO. Cabela’s, Inc.…
Dendreon Corporation (NASDAQ: DNDN) may be losing its favor as the prostate cancer drug of choice. That is at least what the stock reaction is signaling today. A late-stage study from Johnson…
Jon C. Ogg Johnson & Johnson (NYSE: JNJ) is a company that has lost much of a formerly great reputation. Warren Buffett even admitted that today. In an on and off 3-hour interview earlier this…
As Bill Weldon leaves the headquarters of Johnson & Johnson (NYSE: JNJ), probably many years from now, he will know that his tenure will be remembered for hip replacement and children’s Tylenol recalls…
Douglas A. McIntyre Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of December 30, 2011. These public stock holdings have been broken down into…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. PhRMA represents leading pharmaceutical research and biotechnology companies and some of the…
Shares of development-stage drug maker Medivation Inc. have risen sharply today as the company said that its MDV3100 late-stage prostate cancer drug for patients who have failed chemotherapy extends life expectancy by…
Paul Ausick Johnson & Johnson (NYSE: JNJ) managed to marginally beat earnings expectations this Tuesday morning. This is the first of the consumer products and medical products companies to report, so this one could…
Jon C. Ogg This coming week is going to be yet another action packed week of big corporate earnings which will move markets or will move their sectors. 24/7 Wall St. has identified each of…
The coming week is going to be yet another action packed week of big corporate earnings which will move markets or will move their sectors. 24/7 Wall St. has identified the DJIA…
The Janssen Pharmaceuticals unit of Johnson & Johnson (NYSE: JNJ) has reached an agreement with the state of Texas to pay $158 million to settle all claims related to overcharging the state’s…
Paul Ausick Customers, employees, shareholders and taxpayers hate large corporations for many reasons. 24/7 Wall St. reviewed a lengthy list of corporations for which there is substantial research data to choose the 10 most…